Nutex Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Nutex Health (NUTX).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$289Upside to Avg. PT+40.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 25, 2026	Freedom Capital Markets	Gene Mannheimer	PT Raise	Buy	$280→$306
Sep 4, 2026	B. Riley Securities	Yuan Zhi	PT Raise	Buy	$290→$325
Aug 11, 2026	Lake Street	Ben Haynor	PT Raise	Buy	$235→$310
Jun 26, 2026	B. Riley Securities	Anderson Schock	Initiate	Buy	$290
Jun 2, 2026	Lake Street	Ben Haynor	Initiate	Buy	$235
Aug 26, 2025	Maxim Group	Anthony Vendetti	PT Cut	Buy	$225→$205
Jul 10, 2025	Benchmark	Bill Sutherland	Maintained	Buy	$300
May 20, 2025	Maxim Group	Anthony Vendetti	PT Raise	Buy	$100→$225
May 15, 2025	Benchmark	Bill Sutherland	PT Raise	Buy	$150→$300
Apr 9, 2025	Benchmark	Bill Sutherland	PT Raise	Buy	$60→$150
Apr 8, 2025	Maxim Group	Anthony Vendetti	PT Raise	Buy	$75→$100
Feb 13, 2025	Maxim Group	Anthony Vendetti	PT Raise	Buy	$50→$75
Nov 12, 2024	Maxim Group	Anthony Vendetti	PT Raise	Buy	$45→$50
Nov 12, 2024	Benchmark	Bill Sutherland	PT Raise	Buy	$45→$60
Sep 18, 2024	Maxim Group	Anthony Vendetti	Initiate	Buy	$45
Aug 21, 2024	Benchmark	Bill Sutherland	PT Raise	Buy	$30→$45
Jan 25, 2024	Benchmark	Bill Sutherland	PT Cut	Buy	$2→$1
Nov 14, 2023	Benchmark	Bill Sutherland	PT Cut	Buy	$3→$2

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306

Freedom Capital Markets analyst Gene Mannheimer maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $280 to $306.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

B. Riley Securities analyst Yuan Zhi maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $290 to $325.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $310

Lake Street analyst Ben Haynor maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $235 to $310.

Benzinga Newsdesk

PRO
B. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290

B. Riley Securities analyst Anderson Schock initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $290.

Benzinga Newsdesk

PRO
Lake Street Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $235

Lake Street analyst Ben Haynor initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $235.

Benzinga Newsdesk

PRO
Maxim Group Maintains Buy on Nutex Health, Lowers Price Target to $205

Maxim Group analyst Anthony Vendetti maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $225 to $205.

Benzinga Newsdesk

Nutex Health Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Nutex Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306

PRO
B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

PRO
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $310

PRO
B. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290

PRO
Lake Street Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $235

PRO
Maxim Group Maintains Buy on Nutex Health, Lowers Price Target to $205

People Also Watch

People Also Watch

Nutex Health Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Nutex Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROFreedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306

PROB. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

PROLake Street Maintains Buy on Nutex Health, Raises Price Target to $310

PROB. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290

PROLake Street Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $235

PROMaxim Group Maintains Buy on Nutex Health, Lowers Price Target to $205

People Also Watch

People Also Watch

PRO
Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306

PRO
B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

PRO
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $310

PRO
B. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290

PRO
Lake Street Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $235

PRO
Maxim Group Maintains Buy on Nutex Health, Lowers Price Target to $205